Compare ImmunityBio Inc. Common Stock (IBRX) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.6× Relay Therapeutics Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 3,432,928). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| IBRX | RLAY | |
|---|---|---|
Market Cap | $10.33B | $3.94B |
Volume | 11,745,198 | 3,432,928 |
Sector | Health | Health |
52-Week High | $11.55 | $20.75 |
52-Week Low | $1.98 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $3.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
